Recent

% | $
Quotes you view appear here for quick access.

Seattle Genetics, Inc. Message Board

  • brusselsgriffon2 brusselsgriffon2 Mar 18, 2013 9:01 PM Flag

    Anyone remember the Zach sell?

    This may make them reconsider stay long there may be no dips to buy more.

    At the 2011 ASH Annual Meeting, prolonged treatment data were reported from 17 patients with a median duration of treatment of 17.3 months (approximately 24 cycles of every three week dosing). The overall objective response rate with extended treatment was 88 percent, including 76 percent complete remissions and 12 percent partial remissions. ADCETRIS was generally well-tolerated, with the most common adverse events being peripheral neuropathy (71 percent), upper respiratory infection (53 percent) and fatigue (47 percent). Prolonged treatment with ADCETRIS was associated with clinically meaningful durations of response without worsening of toxicity over time.

 
SGEN
46.63-0.87(-1.83%)1:40 PMEDT